N.A. Sharif

467 total citations
12 papers, 388 citations indexed

About

N.A. Sharif is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, N.A. Sharif has authored 12 papers receiving a total of 388 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cellular and Molecular Neuroscience, 8 papers in Molecular Biology and 2 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in N.A. Sharif's work include Neuropeptides and Animal Physiology (7 papers), Receptor Mechanisms and Signaling (7 papers) and Pharmacological Receptor Mechanisms and Effects (4 papers). N.A. Sharif is often cited by papers focused on Neuropeptides and Animal Physiology (7 papers), Receptor Mechanisms and Signaling (7 papers) and Pharmacological Receptor Mechanisms and Effects (4 papers). N.A. Sharif collaborates with scholars based in United Kingdom, Poland and United States. N.A. Sharif's co-authors include Joel W. Hughes, R.G. Hill, John C. Hunter, R.L. Whiting, Z. P. To, A.D. Michel, Roberto P. Rosenkranz and Richard M. Eglen and has published in prestigious journals such as Brain Research, Trends in Pharmacological Sciences and British Journal of Pharmacology.

In The Last Decade

N.A. Sharif

12 papers receiving 377 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
N.A. Sharif United Kingdom 8 302 242 77 31 29 12 388
Hiroo Kuroda Japan 8 270 0.9× 131 0.5× 64 0.8× 24 0.8× 23 0.8× 16 391
L.L. Iversen United States 11 461 1.5× 303 1.3× 123 1.6× 38 1.2× 38 1.3× 14 549
Choh Hao Li United States 6 268 0.9× 230 1.0× 75 1.0× 29 0.9× 63 2.2× 7 367
Sylvester E. Vizi Hungary 8 266 0.9× 176 0.7× 57 0.7× 26 0.8× 54 1.9× 16 417
Paul F.M. Janssen Belgium 11 365 1.2× 239 1.0× 68 0.9× 29 0.9× 17 0.6× 13 513
Pamela Angwin United States 8 186 0.6× 138 0.6× 32 0.4× 24 0.8× 35 1.2× 10 326
Deanne M. Dean Canada 8 408 1.4× 310 1.3× 126 1.6× 52 1.7× 33 1.1× 8 539
A Naidu United States 4 366 1.2× 296 1.2× 93 1.2× 39 1.3× 27 0.9× 5 430
R P Artymyshyn United States 11 324 1.1× 269 1.1× 83 1.1× 23 0.7× 21 0.7× 11 437
Sally E. Hays United States 13 467 1.5× 343 1.4× 70 0.9× 31 1.0× 73 2.5× 17 624

Countries citing papers authored by N.A. Sharif

Since Specialization
Citations

This map shows the geographic impact of N.A. Sharif's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N.A. Sharif with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N.A. Sharif more than expected).

Fields of papers citing papers by N.A. Sharif

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N.A. Sharif. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N.A. Sharif. The network helps show where N.A. Sharif may publish in the future.

Co-authorship network of co-authors of N.A. Sharif

This figure shows the co-authorship network connecting the top 25 collaborators of N.A. Sharif. A scholar is included among the top collaborators of N.A. Sharif based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N.A. Sharif. N.A. Sharif is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Sharif, N.A.. (2024). Effects of pH on Enzyme Activity in Pakistan. 3(3). 49–59. 1 indexed citations
2.
Sharif, N.A., et al.. (1992). A pharmacological comparison of [3H]GBR12935 binding to rodent striatal and kidney homogenates: Binding to dopamine transporters?. Neurochemistry International. 21(1). 69–73. 4 indexed citations
3.
Sharif, N.A., Z. P. To, & R.L. Whiting. (1991). Analogs of thyrotropin-releasing hormone (TRH): Receptor affinities in brains, spinal cords, and pituitaries of different species. Neurochemical Research. 16(2). 95–103. 13 indexed citations
6.
Sharif, N.A., et al.. (1989). Comparative properties of the dopamine transport complex in dog and rodent brain: striatal [3H]GBR12935 binding and [3H]dopamine uptake. Neurochemistry International. 15(3). 325–332. 12 indexed citations
7.
Sharif, N.A., et al.. (1988). PD117302: a selective agonist for the κ‐opioid receptor. British Journal of Pharmacology. 93(3). 618–626. 58 indexed citations
8.
Sharif, N.A., John C. Hunter, R.G. Hill, & Joel W. Hughes. (1988). [125I]Dynorphin(1–8) produces a similar pattern of κ-opioid receptor labelling to [3H]dynorphin(1–8) and [3H]etorphine in guinea pig brain: A quantitative autoradiographic study. Neuroscience Letters. 86(3). 272–278. 11 indexed citations
9.
Sharif, N.A., R.G. Hill, & Joel W. Hughes. (1987). Quantitative autoradiography of delta opioid receptors in rodent brain using [3H]d-Pen2-d-Pen5-enkephalin as the radioligand. Biochemical Society Transactions. 15(6). 1159–1160. 3 indexed citations
10.
Sharif, N.A., et al.. (1986). Quantitative digital subtraction autoradiography of brain opioid receptors. Biochemical Society Transactions. 14(4). 688–690. 6 indexed citations
11.
Sharif, N.A.. (1985). Measurement of Neurotransmitter Release in vivo. Trends in Pharmacological Sciences. 6. 418–419. 45 indexed citations
12.
Sharif, N.A.. (1985). Diverse roles of thyrotropin-releasing hormone in brain, pituitary and spinal function. Trends in Pharmacological Sciences. 6. 119–122. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026